MARKET

MRNA

MRNA

Moderna
NASDAQ
50.80
+2.57
+5.33%
After Hours: 50.98 +0.18 +0.35% 19:58 03/31 EDT
OPEN
49.02
PREV CLOSE
48.23
HIGH
51.62
LOW
47.96
VOLUME
8.18M
TURNOVER
--
52 WEEK HIGH
59.55
52 WEEK LOW
22.28
MARKET CAP
20.15B
P/E (TTM)
-7.0026
1D
5D
1M
3M
1Y
5Y
1D
Why Is the SPY ETF Up Today, 3/31/2026?
TipRanks · 13h ago
Oil Tumbles, Nasdaq 100 Jumps 3% As Iran Says It's Ready To Halt Hostilities: 10 Stocks Moving
Benzinga · 15h ago
Moderna (MRNA) Receives a Hold from Bernstein
TipRanks · 15h ago
Option traders moderately bearish in Moderna with shares up 3.7%
TipRanks · 15h ago
Is Trump to blame for delayed drug launches in Europe
Seeking Alpha · 17h ago
Why Is Vanguard S&P 500 ETF (VOO) Up Today, 3/31/2026?
TipRanks · 20h ago
Cathie Wood Adds 48K Shares to This Under-the-Radar Growth Play
Barchart · 23h ago
Why Is Vanguard S&P 500 ETF (VOO) Up Today, 3/30/2026?
TipRanks · 1d ago
More
About MRNA
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).

Webull offers Moderna Inc stock information, including NASDAQ: MRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRNA stock methods without spending real money on the virtual paper trading platform.